(0)
Experienced sales leader Ciaran Avitabile joins as Global Head of Sales
Clinical trials software provider Teckro announces growth of its executive team to build on 2020 s momentum that includes more than 19,800 sites globally reliant on Teckro and the expansion of its digital engagement platform to give site staff real-time communication with study experts.
Now in its 6
th year, Teckro is building on its mission to humanize the clinical trials process. For too long, research staff and monitors and sponsors have relied on outdated, manual methods of communication. The ability to engage and access critical study information in real-time eases the burden on all clinical trial stakeholders.
BERLIN (dpa-AFX) - Science and technology company Merck KGaA (MKGAY.PK) announced Wednesday that the Independent Data Monitoring Committee (IDMC) recommended on Tuesday to discontinue the bintrafusp
Theralase Technologies Inc.: Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study
TSXV:TLT)(
OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (
PDC ) and their associated drug formulations used to safely and effectively destroy various cancers, bacteria and viruses announced today that Urology Associates P.C. (
UA ) has received site Institutional Review Board (
IRB ) approval to commence a pivotal phase II Non-Muscle Invasive Bladder Cancer (
NMIBC ) Clinical Study to enroll and treat patients with Bacillus Calmette Guerin(
Study II ).
Theralase has central IRB approval to launch a number of US clinical sites, subject to local site IRB approval. UA is the second site to receive both central and local site IRB approval. There are 4 additional US clinical study sites that have received central IRB approval and are expected to receive loca